about
The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and ControlNorovirus Regulation by Host and Microbe.Norovirus Polymerase Fidelity Contributes to Viral Transmission In Vivo.B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant VirusesInterferon-Lambda: A Potent Regulator of Intestinal Viral Infections.Structure-based exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design of potent and permeable inhibitors.Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses.Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11-2015/16.Recent advances in understanding noroviruses.Inhibition of human norovirus by a viral polymerase inhibitor in the B cell culture system and in the mouse model.RNA Sequencing of Murine Norovirus-Infected Cells Reveals Transcriptional Alteration of Genes Important to Viral Recognition and Antigen Presentation.Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.Prospects and Challenges in the Development of a Norovirus Vaccine.Environmental Surveillance of Norovirus Genogroups I and II for Sensitive Detection of Epidemic Variants.Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease.Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.Comparative phylogenetic analyses of recombinant noroviruses based on different protein-encoding regions show the recombination-associated evolution pattern.Emergence of Novel Human Norovirus GII.17 Strains Correlates with Changes in Blockade Antibody Epitopes.Estimating the burden of medically-attended norovirus gastroenteritis: modelling linked primary care and hospitalization datasets.The epidemiology of Norovirus in the Middle East and North Africa (MENA) region: a systematic review.Changes in the numbers of patients with acute gastroenteritis after voluntary introduction of the rotavirus vaccine in a Japanese children's primary emergency medical center.Airborne or Fomite Transmission for Norovirus? A Case Study Revisited.Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease.Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level.Antigenic characterization of a novel recombinant GII.P16-GII.4 Sydney norovirus strain with minor sequence variation leading to antibody escape.Big Data Meet Precision Public Health: The Modeling of Acute Gastroenteritis, Norovirus and Its Present and Future Utility.The Incidence of Acute Gastrointestinal Illness in Canada, Foodbook Survey 2014-2015.TLR7 agonists display potent antiviral effects against norovirus infection via innate stimulation.Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and its Opportunity Costs for Non-Admitted Patients.Efficacy of silver dihydrogen citrate and steam vapor against a human norovirus surrogate, feline calicivirus, in suspension, on glass, and carpet.Asymptomatic norovirus infection associated with swimming at a tropical beach: A prospective cohort study.Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro.In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase.Emerging recombinant noroviruses identified by clinical and waste water screening.Tissue Distribution and Visualization of Internalized Human Norovirus in Leafy Greens.Mouse Norovirus infection reduces the surface expression of MHC class I proteins and inhibits CD8+ T cell recognition and activationAntiviral activities of var. essential oil and its α-thujone against norovirus surrogatesCharacterization of intra- and inter-host norovirus P2 genetic variability in linked individuals by amplicon sequencing
P2860
Q26749653-6F2CDF5A-00E9-4B73-A453-EFCA4FA7D756Q30240631-21B9F561-C0EA-4B48-A91B-A83600C4814CQ30394471-0A89F773-47BC-4A17-BF05-7CA4CAC716B2Q33654573-836262E0-C061-48AD-B146-054E1A476AE5Q33832855-AC181040-06C8-4579-B125-A76191C9484DQ33854465-82E90F23-26EE-4C31-BC6F-DCD165A0E97AQ33883350-113F02C7-9791-4241-B1E9-4B39DE9CB977Q37590280-BC8B9C48-13D5-41FC-806D-9EACA476169EQ38374766-C9154D08-296B-42C7-91A9-D2DA9F05B4A7Q38759466-F6E042AE-592B-467D-9F90-024881C1BF33Q38761262-80807A64-21FB-4332-816E-2D76A51F339DQ38769315-9F14A6B1-D26D-4D55-B218-12E19D50CB09Q40067139-87A911D7-45E9-403F-9954-0381E5B6F182Q40093537-F63B1200-E97D-4983-AA36-A93C8F555AE8Q40102851-5A1BE2E3-7EF1-44F3-9DE5-7ABB062CCDF5Q40327653-90217286-6536-4AE3-861A-E4FF289E1DB2Q40390221-DBF3D8E9-1D20-48D6-B105-347B0B69AF33Q40632645-185A4CAC-4EF0-45C4-B047-F14B4961BBA7Q41711829-AE5C90A5-18EF-4A89-86DD-48FE5AD7D75CQ41925431-B2AEEE1A-7979-472F-81B2-2823F9DB4F70Q41992936-E4985E7C-45A8-4FC4-8AA0-04B8EC86BF2FQ45308230-DC14DB89-6652-4248-860B-B0337FAADC0EQ47114879-AABFD8E6-B981-4A42-981E-AFA397B1D9B6Q47250119-4A8D3A80-3F4D-47F1-9436-AE3DCD712F7FQ47308003-EF34E231-326E-42EC-A82F-47D54F06D9F2Q47557837-A9C1BE28-EA9A-4E4A-9337-73926E7FD58EQ47560237-20A9FDA9-A143-4BAD-960C-52F8AC029016Q47897636-D855DF02-50D2-4E12-97F0-4B4F2C928DC4Q48095260-59802AB8-33A9-45BD-8D7D-31B9CDDDDD98Q51741116-DDA54DB9-94C2-4560-A31C-5979DB52251DQ51783959-80192BDB-4C14-414C-A058-1490D391D982Q52601753-D6CC57D4-A640-45F4-B63A-5431AE33A466Q52625590-5E7C8702-106F-41D2-BAD1-A7A809BDA826Q52659751-345A1E0B-4296-4EF2-8C51-2A4564D4CAF9Q52668531-DD9A332F-51D1-4945-B896-DC41BAE1CB58Q53076721-498528DC-65C5-42F2-9C11-77DB818F7A04Q54240301-381CBD64-B007-49E8-B4EC-A28F3E262D1BQ56877862-25BF440B-45F8-4D80-B123-0403C8818B90Q57027250-BA370AA7-2789-4647-A340-691BF9B770C3Q57080939-97B2074F-063D-4014-81E8-D0FAA64F6F9F
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Global Economic Burden of Norovirus Gastroenteritis.
@ast
Global Economic Burden of Norovirus Gastroenteritis.
@en
type
label
Global Economic Burden of Norovirus Gastroenteritis.
@ast
Global Economic Burden of Norovirus Gastroenteritis.
@en
prefLabel
Global Economic Burden of Norovirus Gastroenteritis.
@ast
Global Economic Burden of Norovirus Gastroenteritis.
@en
P2860
P50
P1433
P1476
Global Economic Burden of Norovirus Gastroenteritis.
@en
P2860
P304
P356
10.1371/JOURNAL.PONE.0151219
P407
P577
2016-04-26T00:00:00Z